FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004705473> ?p ?o ?g. }

• W2004705473 endingPage "753" @default.
• W2004705473 startingPage "753" @default.
• W2004705473 abstract "Acute myeloid leukemia (AML) is a hematopoietic stem cell disorder that affects approximately 14,000 persons each year in the US. AML occurs at all ages but the incidence increases with age with the median age at diagnosis being 67 years. Advances in the treatment of AML over the past decades have led to improved survival, albeit mostly in younger patients. The prognosis of older patients with this disease over the same time span has not changed much and remains dismal. This review focuses on the epidemiology and characteristics of AML in elderly patients, the rationale for treating elderly AML patients, and the currently available and potential future treatment options such as sapacitabine. Elderly AML patients treated with intensive chemotherapy have a higher mortality rate, and a lower rate of complete remission and overall survival when compared to the younger population. This is due to both the different biology of the disease and the number of patient-specific factors. However, elderly AML patients treated with aggressive chemotherapy can achieve durable remissions, which offer prolonged survival and improved quality of life. Recent data also indicates that elderly AML patients deemed unfit for intensive chemotherapy benefit from leukemia-specific attenuated dose chemotherapy compared to supportive care alone. This has led to renewed interest to look for anti-leukemic therapies designed specifically for older patients. Sapacitabine, a novel oral nucleoside analog, promises good efficacy, favorable toxicity profile, and ease of administration; all of which makes it very appealing. Results from pre-clinical and clinical studies have been very encouraging and sapacitabine is currently being evaluated in a Phase III study, of which the results are eagerly awaited." @default.
• W2004705473 created "2016-06-24" @default.
• W2004705473 creator A5028241860 @default.
• W2004705473 creator A5044794766 @default.
• W2004705473 date "2014-05-01" @default.
• W2004705473 modified "2023-09-23" @default.
• W2004705473 title "Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients" @default.
• W2004705473 cites W1869406861 @default.
• W2004705473 cites W1909698311 @default.
• W2004705473 cites W1969368033 @default.
• W2004705473 cites W1970946990 @default.
• W2004705473 cites W1972047494 @default.
• W2004705473 cites W1978926685 @default.
• W2004705473 cites W1986769067 @default.
• W2004705473 cites W1999705499 @default.
• W2004705473 cites W2006074459 @default.
• W2004705473 cites W2035918192 @default.
• W2004705473 cites W2038013499 @default.
• W2004705473 cites W2041027929 @default.
• W2004705473 cites W2043346629 @default.
• W2004705473 cites W2051644137 @default.
• W2004705473 cites W2057899441 @default.
• W2004705473 cites W2058188142 @default.
• W2004705473 cites W2065285477 @default.
• W2004705473 cites W2068556430 @default.
• W2004705473 cites W2079025304 @default.
• W2004705473 cites W2081391009 @default.
• W2004705473 cites W2081576971 @default.
• W2004705473 cites W2084863738 @default.
• W2004705473 cites W2097035477 @default.
• W2004705473 cites W2102027103 @default.
• W2004705473 cites W2106084333 @default.
• W2004705473 cites W2107029748 @default.
• W2004705473 cites W2107873824 @default.
• W2004705473 cites W2109065151 @default.
• W2004705473 cites W2114942826 @default.
• W2004705473 cites W2126217509 @default.
• W2004705473 cites W2126572589 @default.
• W2004705473 cites W2131662130 @default.
• W2004705473 cites W2133650635 @default.
• W2004705473 cites W2137881702 @default.
• W2004705473 cites W2141666493 @default.
• W2004705473 cites W2142262551 @default.
• W2004705473 cites W2144310977 @default.
• W2004705473 cites W2145124830 @default.
• W2004705473 cites W2147010550 @default.
• W2004705473 cites W2153310476 @default.
• W2004705473 cites W2157287007 @default.
• W2004705473 cites W2159738043 @default.
• W2004705473 cites W2160968219 @default.
• W2004705473 cites W2162700652 @default.
• W2004705473 cites W2165846604 @default.
• W2004705473 cites W2169319915 @default.
• W2004705473 cites W2576450753 @default.
• W2004705473 cites W2594742369 @default.
• W2004705473 cites W2764775166 @default.
• W2004705473 cites W2951317241 @default.
• W2004705473 cites W48493600 @default.
• W2004705473 doi "https://doi.org/10.2147/cia.s39558" @default.
• W2004705473 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4018315" @default.
• W2004705473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24851045" @default.
• W2004705473 hasPublicationYear "2014" @default.
• W2004705473 type Work @default.
• W2004705473 sameAs 2004705473 @default.
• W2004705473 citedByCount "6" @default.
• W2004705473 countsByYear W20047054732015 @default.
• W2004705473 countsByYear W20047054732017 @default.
• W2004705473 countsByYear W20047054732018 @default.
• W2004705473 crossrefType "journal-article" @default.
• W2004705473 hasAuthorship W2004705473A5028241860 @default.
• W2004705473 hasAuthorship W2004705473A5044794766 @default.
• W2004705473 hasBestOaLocation W20047054731 @default.
• W2004705473 hasConcept C120665830 @default.
• W2004705473 hasConcept C121332964 @default.
• W2004705473 hasConcept C126322002 @default.
• W2004705473 hasConcept C143998085 @default.
• W2004705473 hasConcept C177713679 @default.
• W2004705473 hasConcept C179755657 @default.
• W2004705473 hasConcept C187212893 @default.
• W2004705473 hasConcept C2776694085 @default.
• W2004705473 hasConcept C2778461978 @default.
• W2004705473 hasConcept C2778729363 @default.
• W2004705473 hasConcept C2779134260 @default.
• W2004705473 hasConcept C2908647359 @default.
• W2004705473 hasConcept C61511704 @default.
• W2004705473 hasConcept C71924100 @default.
• W2004705473 hasConcept C99454951 @default.
• W2004705473 hasConceptScore W2004705473C120665830 @default.
• W2004705473 hasConceptScore W2004705473C121332964 @default.
• W2004705473 hasConceptScore W2004705473C126322002 @default.
• W2004705473 hasConceptScore W2004705473C143998085 @default.
• W2004705473 hasConceptScore W2004705473C177713679 @default.
• W2004705473 hasConceptScore W2004705473C179755657 @default.
• W2004705473 hasConceptScore W2004705473C187212893 @default.
• W2004705473 hasConceptScore W2004705473C2776694085 @default.
• W2004705473 hasConceptScore W2004705473C2778461978 @default.
• W2004705473 hasConceptScore W2004705473C2778729363 @default.
• W2004705473 hasConceptScore W2004705473C2779134260 @default.

• next